Study Details

General Information

Purdue Pharma CLBP ONU3701

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial with an Enriched Study Design to Assess the Efficacy and Safety of Oxycodone/Naloxone Controlled-Release Tablets (OXN) Compared to Placebo in Opioid-Experienced Subjects with Moderate to Severe Pain Due to Chronic Low Back Pain who Require Around-the-clock Opioid Therapy.

Protocol
IdentifierONU3701
UID185423f5-e912-43cb-91ff-62439f444a61
StatusDone - Archived
Phase3
CategoryLow Back Pain
Launch Year2011
NCT Number-
Created2011-04-06 16:52
Last Updated2011-04-06 16:52

Description

No description provided.

Comment

No comment.

Target Dates

NameDateRequired
Enrollment Closed2012-05-25No
Enrollment OpenNo
First Patient First VisitNo
Site Initiation Mtg.2011-09-01No
PI Meeting StartNo
PI Meeting EndNo
PI Meeting ArrivalNo
PI Meeting DepartureNo
Closeout Date2012-12-21No
Final PatientVisitNo
PreStudy Selection VisitNo
Target Date 12No
Target Date 13No
Target Date 14No

Leadership

RoleStaffLoginRequired
PrincipalMohaupt, StephenSMohauptNo
Recruiter-No
CoordinatorMata, NellyNMataNo
Regulatory-No

Custom Fields

No custom fields.

Sponsor & Organization

SponsorPurdue Pharma LP
DivisionPurdue Pharma LP
TeamPurdue Pharma LP
Managing SiteCatalina Research Institute, LLC
Organization

Contacts

IRB Ref26036/14
CROPPD Investigator Services, LLC
CRO Ref
Correspondence0

Opportunity

Probability0
Comment
Status ColorGainsboro
Currency-
Mayra Sibley

2 Hours

Hi there, I'm Jesse and you?
You

3 minutes

My name is Anne Clarc.
Mayra Sibley

40 seconds

Nice to meet you Anne.
How can i help you?